FDA approves GSK vaccine to combat meningococcal infections
The US Food and Drug Administration (FDA) approved British drug maker GSK's combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company said on Saturday.
Meningococcal infections, caused by bacteria called Neisseria meningitidis, can lead to severe, sometimes deadly, bloodstream infections as well as severe swelling in the brain and spinal cord.
The vaccine, called Penmenvy, combines the immune response-generating components of two of the company's approved vaccines, Bexsero and Menveo, to protect against the five most common strains of meningococcal bacteria, according to a GSK statement.
In 2023, there were 438 confirmed and probable cases of meningococcal disease reported in the United States, according to the US Centres for Disease Control and Prevention (CDC).
Cases of meningococcal disease have increased sharply since 2021, now exceeding pre-pandemic levels in the US, according to the CDC.
'Having a combined vaccine which will offer these vaccines in one injection can simplify the vaccination, which can help improve vaccination rate,' said Patty Sabey, a paediatrician with Stanford Medicine Children's Health.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
4 days ago
- South China Morning Post
5 ways smoking causes damage beyond lungs and heart, and issues from herpes to infertility
Are you a smoker – or does someone you love smoke? If so, you, or they, have almost certainly had family, friends or colleagues give them reasons to stop. Advertisement On World No Tobacco Day, we are reminded that most smokers themselves would like to quit – even if they will not admit it. In 2022, more than two-thirds (67.7 per cent) of the 28.8 million US adults who smoked cigarettes wanted to quit, more than half (53.3 per cent) tried to quit, but fewer than 10 per cent succeeded, according to the US Centres for Disease Control and Prevention (CDC). Grisly photos on cigarette packs warn of smoking's dangers , but do not go far enough, says Tony Mok, professor of clinical oncology at the Chinese University of Hong Kong. Health warnings on cigarette packs. Some say they aren't enough to deter people from lighting up. Photo: Elizabeth Cheung 'The horrid pictures are merely a visual tool, but not an educational one,' he says. 'The potential harm [from] tobacco smoking is too extensive to be listed on cigarette packets.' Advertisement
South China Morning Post
25-05-2025
- South China Morning Post
Covid cases reaching a peak in China and will start falling next month: leading expert
Covid-19 infections in China are reaching a peak and will start to decline next month, the country's best known respiratory diseases specialist has said, as the authorities urged the public to take precautions. Zhong Nanshan told the opening of the Guangzhou Science and Technology and Activity Week on Saturday that people with symptoms – particularly the elderly – should seek medical treatment within 48 hours. He said that in the current cycle, the virus was more infectious and the symptoms were similar to general influenza but with a more obvious sore throat, according to Shanghai-based news site 'This round of coronavirus infections is at its peak and is predicted to decline in June,' said Zhong, who is often described as China's Anthony Fauci. 'From March to May, the number of people infected with the coronavirus has risen, according to data from Hong Kong, Singapore, Britain, France, Brazil and Norway.' Citing data from the Chinese Centres for Disease Control and Prevention (CDC), he said that between March 31 and May 4, tests on outpatients with flu symptoms and hospital patients with severe symptoms had seen an increase in the number of positives from 7.5 per cent to 16.2 per cent. However, the overall number of acute respiratory infectious diseases remained at a low level, according to the CDC report released on May 8, but there was an upward trend in the number of positives in April. Test results showed that all detected pathogens were known common ones and no unknown pathogens or newly emerging infectious diseases had been found.
South China Morning Post
22-05-2025
- South China Morning Post
China's 2019 fentanyl embargo led to drop in US overdoses, study finds
US President Donald Trump angered Beijing when he cited China's involvement in the fentanyl trade as the reason for imposing tariffs in February. But new research indicates that cooperation between the two nations to crack down on the drug's trafficking can disrupt its supply chain and reduce overdose deaths. A paper by the Peterson Institute for International Economics this month found that a 2019 embargo by China on the export of fentanyl and precursor chemicals caused a temporary spike in the drug's street price in the US, which deterred its use and reduced fentanyl-related overdose deaths by up to 25 per cent over a period of three to five months. Beijing imposed a strict drug control policy in May 2019, adding all fentanyl-related substances to its list of controlled substances, restricting their export. 'The Chinese embargo of fentanyl exports to the United States in May 2019 does appear to have affected prices,' the paper said, estimating that absent China's restrictions, as many as 947 more Americans would have died from a fentanyl overdose. The Centres for Disease Control and Prevention (CDC) estimated that nationwide deaths from fentanyl overdoses from May 1 to August 1 in 2019 was 2,254, rising to 3,807 by October 1, with the total death toll for the year estimated at 34,268. Despite the drug's addictive nature, the study found, users responded to price changes: a price rise of 1 per cent was associated with a decrease of as much as 4 per cent in the monthly growth rate of fentanyl-related overdose deaths.
